Building a Global Contamination Control Strategy/Program
Posted on March 5, 2021
Lynn Johnson, Global Microbiology Management
Christoph Hansy, Global Microbiology Management
Takeda Pharmaceuticals
Introduction The necessity – from a patient and business perspective – along with increased pressure from regulators to establish contamination control programs at pharmaceutical manufacturing facilities, has led to a need to define what elements would comprise such a program and how would the p...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter
We will not sell or give your information to a third party. See our Privacy Policy